PULMONARY TUBERCULOSIS WITH MULTIPLE DRAG-RESISTANT M. TUBERCULOSIS IN PATIENTS WITH DIABETES MELLITUS

Abstract

The aim of the study was to study the clinical manifestations and effectiveness of treatment of pulmonary tuberculosis with multidrug-resistant (MDR M. tuberculosis (MTB) in patients with different types of diabetes mellitus (DM). 66 patients with pulmonary tuberculosis combined with type 1 diabetes mellitus and 48 patients with pulmonary tuberculosis combined with type 2 diabetes were examined. It was found that in patients with type 1 DM, MDR tuberculosis was more often observed in men under 40 years of age, in the form of infiltrative pulmonary tuberculosis with the presence of destruction in lung tissue up to 2 cm in diameter with positive sputum and acute intoxication. In patients with type 2 DM, MDR tuberculosis was more often observed in men over the age of 40 in the form of fibrous-cavernous tuberculosis with the presence of destruction in lung tissue larger than 2 cm in diameter, with positive sputum and moderately severe intoxication. The effectiveness of treatment for negativation sputum in the compared groups did not differ significantly and amounted to 71,2% and 64,7%, respectively. However, to close the caverns in the lung, the treatment was more effective in patients with type 1 diabetes, which is probably due to the peculiarities of the tuberculosis process in this category of patients.

Keywords

pulmonary tuberculosis / multiple drug resistance / diabetes mellitus

References

[1] World Health Organization, Global tuberculosis report 2017. http://www.who.int/tb/publications/global_report/en/ (Accessed 2 August 2017)

[2] Нечаева О.Б. Эпидемиологических показателей по туберкулезу за 2016 год. [Электронный ресурс]: http://www.mednet.ru/ru/czentr-monitoringa-tuberkuleza.html

[3] IDF Diabetes Atlasт Eighth Edition 2017. IDF [Official website]. http://www.idf.org/diabetesatlas

[4] Комиссарова О.Г., Абдуллаев Р.Ю., Михайловский А.М. Сахарный диабет как фактор риска развития туберкулеза: патофизиологические аспекты. Медицинский альянс. 2017; 3: 28-34.

[5] Смурова Т.Ф., Ковалева С.И. Туберкулез и сахарный диабет. М.: Медкнига, 2007; 317.

[6] Jeon C.Y., Murray M.B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5 (7):e152

[7] Комиссарова О.Г., Абдуллаев Р.Ю., Коняева О.О., Михайловский А.М. Распространенность, клинические проявления и эффективность лечения туберкулеза у больных сахарным диабетом. Врач. 2017; 2: 24-8.

[8] Pablos-Méndez A., Blustein J., Knirsch C.A. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am. J. Public Health. 1997; 87 (4): 574-9.

[9] Дедов И.И. Инновационные технологии в лечении и профилактике сахарного диабета и его осложнений. Сах. диабет. 2013; 3: 4-10.

[10] Каминская Г.О., Абдуллаев Р.Ю. Патофизиологические предпосылки неблагоприятного влияния сахарного диабета на течение туберкулеза легких. Туберкулез и болезни легких. 2014; 3: 5-10.

[11] Bashar M., Alcabes P., Rom W.N., Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001; 120 (5): 1514-19.

[12] Fisher-Hoch S.P., Whitney E., McCormick J.B. et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand. J. Infect. Dis. 2008; 40(11-12): 888-93.

RIGHTS & PERMISSIONS

Eco-Vector